Related references
Note: Only part of the references are listed.Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System onle Platelets in Systemic Lupus Erythematosus
Christian Lood et al.
PLOS ONE (2014)
Kynurenines in CNS disease: regulation by inflammatory cytokines
Brian M. Campbell et al.
FRONTIERS IN NEUROSCIENCE (2014)
Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice
Daniel Duerschmied et al.
BLOOD (2013)
The interferon signature in autoimmune diseases
Lars Ronnblom et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer
Line V. Iversen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation
Janice J. Kim et al.
JOURNAL OF IMMUNOLOGY (2013)
Serotonin Skews Human Macrophage Polarization through HTR2B and HTR7
Mateo de las Casas-Engel et al.
JOURNAL OF IMMUNOLOGY (2013)
Interleukin 13 and Serotonin: Linking the Immune and Endocrine Systems in Murine Models of Intestinal Inflammation
Md. Sharif Shajib et al.
PLOS ONE (2013)
Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Felix Nau et al.
PLOS ONE (2013)
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus
Anders A. Bengtsson et al.
ARTHRITIS AND RHEUMATISM (2012)
Platelets can enhance vascular permeability
Nathalie Cloutier et al.
BLOOD (2012)
Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease
Mathuravani A. Thevandavakkam et al.
CNS & Neurological Disorders-Drug Targets (2012)
Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease
Jonatan Leffler et al.
JOURNAL OF IMMUNOLOGY (2012)
Platelet serotonin in primary Sjogren's syndrome: Level and relation with disease activity
Helena Sarac et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Quantitative Proteome Profiling of Normal Human Circulating Microparticles
Ole Ostergaard et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis?
C. Lood et al.
LUPUS (2012)
Platelets: active players in the pathogenesis of arthritis and SLE
Eric Boilard et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Distinct Features of Circulating Microparticles and Their Relationship to Clinical Manifestations in Systemic Lupus Erythematosus
Christoffer T. Nielsen et al.
ARTHRITIS AND RHEUMATISM (2011)
Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study
Janette Furuzawa-Carballeda et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
The type I interferon system in the etiopathogenesis of autoimmune diseases
Lars Ronnblom
UPSALA JOURNAL OF MEDICAL SCIENCES (2011)
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
Christian Lood et al.
BLOOD (2010)
Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression
Arne Schaefer et al.
JOURNAL OF HEPATOLOGY (2010)
Pathogenesis of human systemic lupus erythematosus: recent advances
Jose C. Crispin et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Endothelial dysfunction and vascular disease
P. M. Vanhoutte et al.
ACTA PHYSIOLOGICA (2009)
Regulation of the Interferon-α Production Induced by RNA-Containing Immune Complexes in Plasmacytoid Dendritic Cells
Maija-Leena Eloranta et al.
ARTHRITIS AND RHEUMATISM (2009)
Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency
Bangning Yu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The innate immune system in SLE: type I interferons and dendritic cells
L. Roennblom et al.
LUPUS (2008)
Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season
M. Pertovaara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Serotonin activates human monocytes and prevents apoptosis
Fujiko Soga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor
Matilde Leon-Ponte et al.
BLOOD (2007)
5-hydroxytryptamine in the cardiovascular system: Focus on the serotonin transporter (sert)
Wei Ni et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies
Jing Hua et al.
ARTHRITIS AND RHEUMATISM (2006)
5-hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes
T Dürk et al.
INTERNATIONAL IMMUNOLOGY (2005)
Microarray analysis of gene expression in lupus
MK Crow et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells
T Ito et al.
CIRCULATION (2000)
Enhanced tryptophan degradation in systemic lupus erythematosus
B Widner et al.
IMMUNOBIOLOGY (2000)
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
AA Bengtsson et al.
LUPUS (2000)
Share Paper
